Myriam Curet - Intuitive Surgical Senior Vice President Chief Medical Officer
ISRG Stock | USD 366.34 6.29 1.69% |
President
Dr. Myriam J. Curet, M.D. is Executive Vice President, Chief Medical Officer of the Company. In February 2014, Dr. Curet joined Intuitive Surgical in December 2005 as Chief Medical Advisor. In February 2014, Dr. Curet was promoted to the position of Senior Vice President and Chief Medical Officer. In November 2017, Dr. Curet was promoted to the position of Executive Vice President and Chief Medical Officer. Dr. Curet also held a faculty position as Professor of Surgery at Stanford University. Since October 2010, she has served as a Consulting Professor of Surgery at Stanford University with a part time clinical appointment at the Palo Alto Veterans Administration Medical Center. Dr. Curet received her M.D. from Harvard Medical School and completed her general surgery residency program at the University of Chicago. She then worked for the Indian Health Service for four years before finishing her Surgical Endoscopy fellowship at the University of New Mexico. She was on the faculty at the University of New Mexico for six years prior to joining the Stanford University Department of Surgery in 2000. since 2017.
Age | 61 |
Tenure | 7 years |
Address | 1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304 |
Phone | 408 523 2100 |
Web | https://www.intuitive.com |
Latest Insider Transactions
Intuitive Surgical Management Efficiency
The company has return on total asset (ROA) of 0.0777 % which means that it generated a profit of $0.0777 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1483 %, meaning that it created $0.1483 on every $100 dollars invested by stockholders. Intuitive Surgical's management efficiency ratios could be used to measure how well Intuitive Surgical manages its routine affairs as well as how well it operates its assets and liabilities. The Intuitive Surgical's current Return On Tangible Assets is estimated to increase to 0.13. The Intuitive Surgical's current Return On Capital Employed is estimated to increase to 0.13. At this time, Intuitive Surgical's Other Current Assets are most likely to increase significantly in the upcoming years. The Intuitive Surgical's current Total Current Assets is estimated to increase to about 8.3 B, while Other Assets are projected to decrease to roughly 1.1 B.Similar Executives
Showing other executives | PRESIDENT Age | ||
Sam Samad | Illumina | 48 | |
Joseph LaPlume | Charles River Laboratories | 50 | |
Mark Stevenson | Thermo Fisher Scientific | 57 | |
Mark Oene | Illumina | 45 | |
Samraat Raha | Agilent Technologies | 51 | |
John Lynch | Waters | N/A | |
Nicholas Naclerio | Illumina | 53 | |
Henrik AncherJensen | Agilent Technologies | 59 | |
Sherry Buck | Waters | 55 | |
Alicia Rodriguez | Agilent Technologies | N/A | |
Alan Malus | Thermo Fisher Scientific | 55 | |
Marcel Roche | Guardant Health | N/A | |
Paul Bianchi | Illumina | 53 | |
Davide Molho | Charles River Laboratories | 47 | |
Michael Boxer | Thermo Fisher Scientific | 58 | |
Rohit Khanna | Waters | 58 | |
Peter Hornstra | Thermo Fisher Scientific | 59 | |
Sanjay Chikarmane | Illumina | N/A | |
Omead Ostadan | Illumina | 46 | |
Andrew Thomson | Thermo Fisher Scientific | 49 | |
Charles Dadswell | Illumina | 65 |
Management Performance
Return On Equity | 0.15 | ||||
Return On Asset | 0.0777 |
Intuitive Surgical Leadership Team
Elected by the shareholders, the Intuitive Surgical's board of directors comprises two types of representatives: Intuitive Surgical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intuitive. The board's role is to monitor Intuitive Surgical's management team and ensure that shareholders' interests are well served. Intuitive Surgical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intuitive Surgical's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Rosa, Chief Commercial Officer and Executive VP | ||
Mark Brosius, Senior Officer | ||
Mark Rubash, Independent Director | ||
Michael Friedman, Director | ||
Gary Loeb, G Officer | ||
Robert DeSantis, Executive Officer | ||
Philip Kim, Head Relations | ||
Keith Leonard, Director | ||
Ian Purdy, Senior Assurance | ||
Julian Nikolchev, Sr Strategy | ||
Gillian EdD, Senior ServicesWorldwide | ||
Jamie Samath, Principal Accounting Officer, VP and Corporate Controller | ||
Gary JD, General VP | ||
Amal Johnson, Independent Director | ||
Craig Barratt, Independent Director | ||
Eric Halvorson, Independent Director | ||
Lonnie Smith, Chairman and Executive Officer | ||
Jami Nachtsheim, Independent Director | ||
Gary Guthart, CEO and President and Director | ||
Marc Bland, GM VP | ||
Alan Levy, Independent Director | ||
Don Kania, Director | ||
Myriam Curet, Senior Vice President Chief Medical Officer | ||
Mark Meltzer, Chief Compliance Officer, Sr. VP and General Counsel | ||
Colin Morales, Senior Vice President - Manufacturing and Service Operations | ||
MD FACS, Executive Officer | ||
Glenn Vavoso, Senior APAC | ||
Salvatore Brogna, Executive VP of Product Operations | ||
Brian Miller, Executive Officer | ||
George Stalk, Independent Director | ||
Amy Ladd, Director | ||
Henry Charlton, Senior Officer | ||
Fredrik Widman, Principal VP | ||
Marshall Mohr, Executive Services | ||
Christopher Carlson, Corporate Research |
Intuitive Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intuitive Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.15 | ||||
Return On Asset | 0.0777 | ||||
Profit Margin | 0.25 % | ||||
Operating Margin | 0.23 % | ||||
Current Valuation | 126.24 B | ||||
Shares Outstanding | 354.45 M | ||||
Shares Owned By Insiders | 0.53 % | ||||
Shares Owned By Institutions | 88.26 % | ||||
Number Of Shares Shorted | 3.41 M | ||||
Price To Earning | 69.96 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Intuitive Stock analysis
When running Intuitive Surgical's price analysis, check to measure Intuitive Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intuitive Surgical is operating at the current time. Most of Intuitive Surgical's value examination focuses on studying past and present price action to predict the probability of Intuitive Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intuitive Surgical's price. Additionally, you may evaluate how the addition of Intuitive Surgical to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Intuitive Surgical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intuitive Surgical. If investors know Intuitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intuitive Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.857 | Earnings Share 5.03 | Revenue Per Share 20.285 | Quarterly Revenue Growth 0.165 | Return On Assets 0.0777 |
The market value of Intuitive Surgical is measured differently than its book value, which is the value of Intuitive that is recorded on the company's balance sheet. Investors also form their own opinion of Intuitive Surgical's value that differs from its market value or its book value, called intrinsic value, which is Intuitive Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intuitive Surgical's market value can be influenced by many factors that don't directly affect Intuitive Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intuitive Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intuitive Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intuitive Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.